Drug profile · INN
rurioctocog alfa pegol
ADYNOVI
rurioctocog alfa pegol (ADYNOVI) is a coagulation factor viii exogenous protein.
EMA: approved PMDA: approved Blood and blood forming organs (B02) B02BD02
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — rurioctocog alfa pegol
- Class
- Blood and blood forming organs (B02)
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.83
Quick answer
rurioctocog alfa pegol (ADYNOVI) is a coagulation factor viii exogenous protein.
Key facts
INN rurioctocog alfa pegol
Brand ADYNOVI
Mechanism Coagulation factor VIII exogenous protein
Target Coagulation factor VIII
Therapeutic class Blood and blood forming organs (B02)
ATC code B02BD02
Mechanism of action
Coagulation factor VIII exogenous protein
Primary target: Coagulation factor VIII
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
| PMDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is rurioctocog alfa pegol?
rurioctocog alfa pegol (ADYNOVI) is a coagulation factor viii exogenous protein.
What is the brand name for rurioctocog alfa pegol?
ADYNOVI is a marketed brand name for rurioctocog alfa pegol. Check FDA Drugs@FDA for the current US label holder and prescribing information.